• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化中的自发性和医源性低血糖症。

Spontaneous and iatrogenic hypoglycemia in cystic fibrosis.

作者信息

Hicks Rebecca, Marks Brynn E, Oxman Rachael, Moheet Amir

机构信息

Division of Pediatric Endocrinology, David Geffen School of Medicine, UCLA, 10833 Le Conte Ave., MDCC 22-315, Los Angeles, CA, USA.

Division of Endocrinology and Diabetes, Children's National Hospital, 111 Michigan Avenue NW, Washington, DC, USA.

出版信息

J Clin Transl Endocrinol. 2021 Oct 13;26:100267. doi: 10.1016/j.jcte.2021.100267. eCollection 2021 Dec.

DOI:10.1016/j.jcte.2021.100267
PMID:34745906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8551648/
Abstract

Spontaneous episodes of hypoglycemia can occur in people with cystic fibrosis (CF) without diabetes, who are not on glucose lowering medications. Spontaneous hypoglycemia in CF could occur both in the fasting or postprandial state (reactive hypoglycemia). The pathophysiology of fasting hypoglycemia is thought to be related to malnutrition and increased energy expenditure in the setting of inflammation and acute infections. Reactive hypoglycemia is thought to be due to impaired first phase insulin release in response to a glucose load, followed by a delayed and extended second phase insulin secretion; ineffective counterregulatory response to dropping glucose levels may also play a role. The overall prevalence of spontaneous hypoglycemia varies from 7 to 69% as examined with oral glucose tolerance test (OGTT) or with continuous glucose monitoring (CGM) under free living conditions. Spontaneous hypoglycemia in CF is associated with worse lung function, higher hospitalization rates, and worse clinical status. In addition, patients with CF related diabetes on glucose-lowering therapies are at risk for iatrogenic hypoglycemia. In this article, we will review the pathophysiology, prevalence, risk factors, clinical implications, and management of spontaneous and iatrogenic hypoglycemia in patients with CF.

摘要

患有囊性纤维化(CF)但未患糖尿病且未服用降糖药物的人可能会出现自发性低血糖发作。CF患者的自发性低血糖在空腹或餐后状态(反应性低血糖)下均可能发生。空腹低血糖的病理生理学被认为与营养不良以及炎症和急性感染情况下能量消耗增加有关。反应性低血糖被认为是由于对葡萄糖负荷的第一相胰岛素释放受损,随后是延迟和延长的第二相胰岛素分泌;对血糖水平下降的无效反调节反应也可能起作用。在自由生活条件下,通过口服葡萄糖耐量试验(OGTT)或连续血糖监测(CGM)检查,自发性低血糖的总体患病率在7%至69%之间。CF患者的自发性低血糖与更差的肺功能、更高的住院率和更差的临床状态相关。此外,接受降糖治疗的CF相关糖尿病患者有发生医源性低血糖的风险。在本文中,我们将综述CF患者自发性和医源性低血糖的病理生理学、患病率、危险因素、临床意义及管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed9/8551648/eb515e462859/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed9/8551648/eb515e462859/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ed9/8551648/eb515e462859/gr1.jpg

相似文献

1
Spontaneous and iatrogenic hypoglycemia in cystic fibrosis.囊性纤维化中的自发性和医源性低血糖症。
J Clin Transl Endocrinol. 2021 Oct 13;26:100267. doi: 10.1016/j.jcte.2021.100267. eCollection 2021 Dec.
2
Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.儿童和青年囊性纤维化患者口服葡萄糖耐量试验与连续血糖监测期间的低血糖症。
Pediatr Pulmonol. 2023 Sep;58(9):2495-2504. doi: 10.1002/ppul.26533. Epub 2023 Jun 23.
3
Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.囊性纤维化患者在口服葡萄糖耐量试验中出现低血糖。
Pediatr Pulmonol. 2020 Dec;55(12):3391-3399. doi: 10.1002/ppul.25081. Epub 2020 Oct 16.
4
Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.低血糖在囊性纤维化儿童中很常见,主要见于女性。
Pediatr Diabetes. 2017 Nov;18(7):607-613. doi: 10.1111/pedi.12470. Epub 2016 Nov 22.
5
Spontaneous hypoglycemia in patients with cystic fibrosis.
Eur J Endocrinol. 2007 Mar;156(3):369-76. doi: 10.1530/eje.1.02344.
6
Hypoglycemia in cystic fibrosis: Prevalence, impact and treatment.囊性纤维化中的低血糖症:患病率、影响和治疗。
J Cyst Fibros. 2019 Oct;18 Suppl 2:S19-S24. doi: 10.1016/j.jcf.2019.08.004.
7
Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.口服葡萄糖耐量试验后胰腺功能不全囊性纤维化患者出现低血糖和胰岛功能障碍。
J Clin Endocrinol Metab. 2020 Oct 1;105(10):3179-89. doi: 10.1210/clinem/dgaa448.
8
MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.肺移植后成年囊性纤维化患者的葡萄糖代谢明显延迟胰岛素分泌和高比例未检出的显性糖尿病。
Endocr Pract. 2019 Mar;25(3):254-262. doi: 10.4158/EP-2018-0461.
9
Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.口服葡萄糖耐量试验和持续葡萄糖监测以评估囊性纤维化患者糖尿病的发生情况。
Endocrinol Diabetes Nutr (Engl Ed). 2018 Jan;65(1):45-51. doi: 10.1016/j.endinu.2017.08.008. Epub 2017 Nov 12.
10
Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes.成年囊性纤维化患者口服葡萄糖耐量试验期间低血糖的患病率与囊性纤维化相关性糖尿病的发病风险。
J Cyst Fibros. 2018 Jul;17(4):536-541. doi: 10.1016/j.jcf.2018.03.009. Epub 2018 Apr 19.

引用本文的文献

1
Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis.是时候更换用于囊性纤维化相关糖尿病初步筛查的口服葡萄糖耐量试验了吗?建立与囊性纤维化相关的血糖检测工具。
Ann Med. 2025 Dec;57(1):2514787. doi: 10.1080/07853890.2025.2514787. Epub 2025 Jun 5.
2
Advances in diabetes technology to improve the lives of people with cystic fibrosis.糖尿病技术的进步改善了囊性纤维化患者的生活。
Diabetologia. 2024 Oct;67(10):2143-2153. doi: 10.1007/s00125-024-06223-3. Epub 2024 Jul 12.
3
Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes.

本文引用的文献

1
Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.囊性纤维化相关糖尿病的 CFTR 调节剂治疗效果。
J Diabetes Complications. 2021 Jun;35(6):107845. doi: 10.1016/j.jdiacomp.2020.107845. Epub 2021 Jan 5.
2
The consequences of hypoglycaemia.低血糖的后果。
Diabetologia. 2021 May;64(5):963-970. doi: 10.1007/s00125-020-05366-3. Epub 2021 Feb 7.
3
Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension.超快速赖脯胰岛素(URLi)在1型糖尿病成人患者中的长期疗效和安全性:PRONTO-T1D扩展研究
一名无糖尿病的囊性纤维化患者开始使用CFTR调节剂治疗后出现低血糖症。
Case Rep Endocrinol. 2023 Dec 23;2023:9769119. doi: 10.1155/2023/9769119. eCollection 2023.
4
Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes.仅使用胰岛素的iLet仿生胰腺治疗囊性纤维化相关糖尿病的随机试验。
Diabetes Care. 2024 Jan 1;47(1):101-108. doi: 10.2337/dc23-1411.
5
Reproducibility of in-home CFRD screening using continuous glucose monitoring and mixed meal tolerance test.使用持续葡萄糖监测和混合餐耐量试验进行家庭中CFRD筛查的可重复性。
J Clin Transl Endocrinol. 2023 Aug 25;33:100323. doi: 10.1016/j.jcte.2023.100323. eCollection 2023 Sep.
6
Use of Continuous Glucose Monitors by People Without Diabetes: An Idea Whose Time Has Come?《无糖尿病患者使用连续血糖监测仪:时机已到?》
J Diabetes Sci Technol. 2023 Nov;17(6):1686-1697. doi: 10.1177/19322968221110830. Epub 2022 Jul 20.
Diabetes Ther. 2021 Feb;12(2):569-580. doi: 10.1007/s13300-020-00987-8. Epub 2021 Jan 17.
4
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S73-S84. doi: 10.2337/dc21-S006.
5
Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.囊性纤维化患者在口服葡萄糖耐量试验中出现低血糖。
Pediatr Pulmonol. 2020 Dec;55(12):3391-3399. doi: 10.1002/ppul.25081. Epub 2020 Oct 16.
6
Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.口服葡萄糖耐量试验后胰腺功能不全囊性纤维化患者出现低血糖和胰岛功能障碍。
J Clin Endocrinol Metab. 2020 Oct 1;105(10):3179-89. doi: 10.1210/clinem/dgaa448.
7
Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis.成年囊性纤维化患者口服葡萄糖后低血糖的代偿反应受损。
Diabetologia. 2020 May;63(5):1055-1065. doi: 10.1007/s00125-020-05096-6. Epub 2020 Jan 29.
8
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.依伐卡托与泰比卡托和艾克卡托三联复方药物治疗携带单个 F508del 突变的囊性纤维化
N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31.
9
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.在纯合子 F508del 突变的囊性纤维化患者中,elexacaftor 加 tezacaftor 加 ivacaftor 联合治疗方案的疗效和安全性:一项双盲、随机、3 期临床试验。
Lancet. 2019 Nov 23;394(10212):1940-1948. doi: 10.1016/S0140-6736(19)32597-8. Epub 2019 Oct 31.
10
Cystic fibrosis related diabetes: Nutrition and growth considerations.囊性纤维化相关性糖尿病:营养与生长相关问题。
J Cyst Fibros. 2019 Oct;18 Suppl 2:S32-S37. doi: 10.1016/j.jcf.2019.08.011.